QOF · 2026/27

QOF — Quality & Outcomes Framework 2026/27

Last update

1 June 2026

Data source

Clinical system

Refresh

Weekly · live

Next refresh

Auto · weekly

Indicator type

Date window

PCN & Practice

View as at

KPIs on target

16/39

23 below · 6 monitoring

Performance

80.7%

36 payment KPIs

Highest performing

VI004

85.3% · target 50–60% · +25.3%

480 / 563

Lowest performing

VI002

12.6% · target 86–96% · -83.4%

509 / 4,040

Most improved

—

Needs 2+ uploads

On target (16)Near target (14)Below target (7)No data (8)Mon= Monitoring only — no payment threshold

Indicator⇅	Target⇅	Target activity⇅	Performance %⇅	Activity⇅	Population⇅	Shortfall⇅	Status	Q1 %	Q2 %
Respiratory
AST007Asthma with review in last 12 months▸	45–70%	11,843	74.3%	12,573	16,918	Met	Met	18.6%	37.2%
AST008Asthma aged 19 or under with smoking status or exposureMon▸	Monitoring	—	75.1%	2,412	3,212	—	Monitoring	18.8%	37.6%
AST012Asthma with objective tests recorded▸	45–80%	54	91%	61	67	Met	Met	22.8%	45.5%
COPD010COPD with review including exacerbations, breathlessness▸	50–90%	3,109	83.6%	2,889	3,454	220	Near	20.9%	41.8%
COPD014COPD and MRC >=3 and offered pulmonary rehabilitationMon▸	Monitoring	—	76%	495	651	—	Monitoring	19%	38%
Cardiovascular
AF006Patients with AF and CHA2DS2-VASc score▸	40–95%	1,094	93.5%	1,076	1,151	18	Near	23.4%	46.8%
AF008Patients with AF and a CHA2DS2-VASc score>=2 on DOAC /Vit K antagonist▸	70–95%	1,546	96.2%	1,565	1,627	Met	Met	24.1%	48.1%
BP002Patients aged 45 or over and blood pressure recorded▸	50–90%	81,911	89.8%	81,737	91,012	174	Near	22.5%	44.9%
CHD005CHD taking anti-platelet or anti-coagulant▸	56–96%	5,584	96.3%	5,603	5,816	Met	Met	24.1%	48.2%
CHOL003Patients with CHD / PAD / TIA / CKD on statin/lipid-lowering therapy▸	70–95%	6,873	93.3%	6,750	7,234	123	Near	23.3%	46.7%
CHOL004Patients with LDL cholesterol <=2.0 or non-HDL <=2.6▸	20–50%	3,798	60.8%	4,622	7,596	Met	Met	15.2%	30.4%
HF007Heart failure with review of functional capacity, medication▸	50–90%	1,475	81.9%	1,341	1,638	134	Near	20.5%	41%
HF008Heart failure diagnosis from 1 April 2023 with ECHO or specialist assess▸	50–90%	582	91%	588	646	Met	Met	22.8%	45.5%
HYP008Hypertension aged 79 or under BP 140/90 mmHg or less▸	40–85%	20,658	78.4%	21,031	26,828	Met	Met	19.6%	39.2%
HYP009Hypertension aged 80 or over BP 150/90 mmHg or less▸	40–85%	2,535	84.1%	2,665	3,168	Met	Met	21%	42.1%
STIA007Non-haemorrhagic stroke or TIA taking anti-platelet or anti-coagulant▸	57–97%	1,569	96.7%	1,563	1,617	6	Near	24.2%	48.4%
Cancer
CAN004Cancer care review within 12 monthsMon▸	Monitoring	—	82.5%	553	670	—	Monitoring	20.6%	41.3%
CAN005Cancer support offered within 3 monthsMon▸	Monitoring	—	56.5%	462	817	—	Monitoring	14.1%	28.3%
Dementia
DEM004Dementia and review done▸	35–70%	726	82.8%	859	1,037	Met	Met	20.7%	41.4%
Other
DEPCC01Patients aged 18 or over with a new diagnosis of depression▸	NIS	—	—	1,718	—	—	No data	—	—
Mental Health
DEP004New diagnosis of depression with a review doneMon▸	Monitoring	—	23.8%	132	554	—	Monitoring	6%	11.9%
MH002Mental health and care plan documented▸	40–90%	3,888	75.8%	3,273	4,320	615	Below	19%	37.9%
MH003Mental health problems and BP recorded in the preceding 12 months▸	50–90%	4,003	84.6%	3,764	4,447	239	Near	21.2%	42.3%
MH006Mental health problems and BMI recorded in the preceding 12 months▸	50–90%	4,006	83%	3,696	4,451	310	Near	20.8%	41.5%
MH007Mental health problems and alcohol recorded in last 12 months▸	50–90%	3,978	81.8%	3,615	4,420	363	Near	20.5%	40.9%
MH011Mental health problems and lipids recorded in last 12 months▸	50–90%	3,950	79.9%	3,506	4,388	444	Near	20%	40%
MH012Mental health problems and glucose/Hba1c recorded in last 12 months▸	NIS	—	—	2,677	—	—	No data	—	—
MH021Mental health problems and all 6 elements of physical health check▸	80%	3,677	67.4%	3,097	4,596	580	Below	16.9%	33.7%
Diabetes
DM006Diabetes and proteinuria or micro-albuminuria taking ACE-I or ARB▸	57–97%	2,522	90.9%	2,363	2,600	159	Near	22.7%	45.5%
DM014Newly diagnosed with diabetes referred to structured education programme▸	40–90%	1,040	87.1%	1,006	1,155	34	Near	21.8%	43.6%
DM020Diabetes no moderate/severe frailty IFCC-HbA1c is 58 mmol/mol or less▸	35–75%	15,162	57.5%	11,627	20,216	3,535	Below	14.4%	28.8%
DM021Diabetes with frailty IFCC-HbA1c is 75 mmol/mol or less▸	NIS	—	—	1,918	—	—	No data	—	—
DM034Diabetes aged >=40 no CVD/frailty on statin or lipid-lowering therapy▸	50–90%	11,039	90.5%	11,095	12,265	Met	Met	22.6%	45.3%
DM035Diabetes with CVD (not haemorrhagic) on statin or lipid-lowering therapy▸	50–90%	5,823	95.5%	6,176	6,469	Met	Met	23.9%	47.8%
DM036Diabetes no moderate/severe frailty BP 140/90 mmHg or less▸	38–90%	19,936	84.6%	17,393	20,552	2,543	Near	21.2%	42.3%
NDH002Non-diabetic hyperglycaemia with HbA1c or fasting glucose▸	50–90%	9,184	83.4%	11,969	14,350	Met	Met	20.9%	41.7%
Vaccination & Immunisation
VI001Three or more DTaP vaccine doses before 8 months▸	89–96%	3,009	49.4%	1,548	3,134	1,461	Below	12.4%	24.7%
VI002One or more MMR doses aged 12-18 months▸	86–96%	3,879	12.6%	509	4,040	3,370	Below	3.2%	6.3%
VI003Aged 1-5 years with DTaP/IPV booster and at least 2 doses of MMR▸	81–96%	3,456	67.1%	2,416	3,600	1,040	Below	16.8%	33.6%
VI004Aged 80 with shingles vaccine received between 70-79 years▸	50–60%	338	85.3%	480	563	Met	Met	21.3%	42.7%
Cervical Screening
CS005Aged 25-49 adequate smear last 3 years and 6 months▸	45–80%	59,764	66.5%	49,714	74,704	10,050	Below	16.6%	33.3%
CS006Aged 50-64 adequate smear last 5 years and 6 months▸	45–80%	13,348	82%	13,675	16,684	Met	Met	20.5%	41%
Smoking
SMOK002Chronic disease and smoking status recorded▸	50–90%	54,571	93.7%	56,794	60,634	Met	Met	23.4%	46.9%
SMOK004Current smokers with an offer of support given▸	40–90%	42,248	92.7%	43,505	46,942	Met	Met	23.2%	46.4%
SMOK005Chronic disease and smoking advice givenMon▸	96%	9,591	89.6%	8,954	9,990	637	Near	22.4%	44.8%

Data as of 1 June 2026 · Clinical system · Refreshed weekly